Positioning Medicines for Out-License
We are focused on taking the most promising treatment options through the clinic and then into the hands of pharma partners
Expediting developed medicines
Assets are developed with a focus on out-license requirements
We have a clear development process that ideally positions drugs for effective out-license to the right partners
Using in-depth competitor and data analysis, we appraise the global landscape to ensure we position our medicines to enter the market in the right way
Data packages, registration and approval
We prepare our medicines for out-license by prioritising the needs of regulators and pharmaceutical partners
Learn more about our proposition
